Athersys Inc. (Nasdaq: ATHX), the Cleveland-based regenerative medicine company that is undertaking cost-cutting and restructuring efforts, has named an interim chief financial officer.
The company on Thursday, Aug. 4, announced in a news release that it has named Kasey Rosado to the interim CFO role. Ivor Macleod, the company’s former CFO, left Athersys on June 30 as part of a restructuring announced in early June that is cutting the workforce by 70%.
Rosado, 49, has been a senior managing director with business advisory firm Ankura Consulting Group LLC since 2018, according to this Athersys filing with the U.